Obesity has reached epidemic proportions in our patients who are of childbearing age, with pregnant patients of normal weight being in the minority. The pregnancy-related complications attributable to obesity affect not only the pregnant women, but also her fetus and potentially both mother and child for their lifetimes. Pregnancy is associated with altered immunity. The physiologic state of chronic inflammation in obesity affects systemic immunity and metabolism, and may be associated with several of the complications associated with maternal obesity. The interplay between pregnancy, obesity and inflammation may have far-reaching implications for fertility, pregnancy, the fetus and neonate.
Introduction
In the new millennium, obesity (body mass index, BMIX30 kg/m 2 ) has rapidly evolved into a pandemic. The number of overweight adults worldwide has now surpassed one billion, of whom 300 million are considered clinically obese. 1, 2 Obesity is creating a significant financial burden, accounting for 2% to 7% of annual health-care costs. 1 A known risk factor for multiple medical conditions, obesity has significant health implications across multiple ages and populations. [1] [2] [3] The risks associated with obesity are complex in women of reproductive age. 4 More than half of women aged 18 to 42 in the United States are classified as overweight or preobese (BMI 25 to <30 kg m À2 ), and about one-third are obese. 2, 5 The WHO classifies weight in adults according to BMI, with obesity categorized as 30 to <35, 35 to <40 and >40 for classes I, II and III, respectively (Table 1 ). There is evidence of a 'dose response' of obesity, with increasing risk of several complications directly associated with increasing BMI.
Maternal obesity has been associated with a multitude of complications beginning with infertility and miscarriage, as well as gestational diabetes, gestational hypertension, preeclampsia and delivery complications. 2, [4] [5] [6] Maternal obesity is associated with several fetal and neonatal complications, most significantly fetal death and premature birth. 4, [7] [8] [9] [10] [11] In addition, maternal obesity has been related to the development of metabolic syndrome, diabetes and obesity in children, thus perpetuating this dangerous cycle. 4, 5, 8, 12 With increased infertility, many obese women have looked to assisted reproductive technology such as in vitro fertilization (IVF). 5 IVF has been shown to be less successful in obese women and is associated with an increased number of premature births. 5 Obesity in the nongravid adult can lead to several complications related to inflammation and immune dysregulation. As pregnancy also induces inflammation and changes in the immune system, the interplay between pregnancy, obesity, fetus, and these inflammatory and immune changes may be the cause of the multiple complications encountered in these pregnancies. This article reviews the proinflammatory state of obesity and its effect on metabolic balance during pregnancy, and the relationship between pregnancy, immunity and inflammation. The most common and significant complications for a pregnant woman, her fetus and child as they relate to obesity in pregnancy are reviewed. Finally, perinatal programming will be discussed which can confer a lifelong risk for obesity and metabolic syndrome.
Obesity and inflammation
Obesity induces a physiologic state of chronic, low-grade inflammation with elevated levels of circulating inflammatory markers such as C-reactive protein (CRP), interleukin (IL)-6, IL-8 and tumor necrosis factor (TNF)-a. 2,12 -14 These molecules are associated with atherogenesis, metabolic dysregulation and diabetes. 2, 13, 15, 16 Obese individuals have been found to have larger adipocytes than lean controls. 12, 15, 17 As BMI increases, the adipocytes are altered in ways that affect systemic metabolism. 15, 17 Adipocytes release a number of adipokines (cytokines, growth factors) that affect the endocrine environment at the level of the adipose tissue as well as systemically. 15, 17 Adipocyte size directly correlates with increased expression of TNF-a, IL-6 and leptin, as well as decreased expression of adiponectin. 17 Although leptin regulates appetite through communication between adipose tissue and the hypothalamus in normal weight individuals, obese individuals develop resistance to this form of appetite suppression. 12, [17] [18] [19] In addition, downregulation of adiponectin interferes with glucose transport into peripheral tissues and favors intra-abdominal fat accumulation. 8, 17 In response to elevated levels of proinflammatory adipokines, adipose tissue becomes increasingly populated with macrophages and undergoes tissue necrosis, releasing more inflammatory mediators and propagating the inflammatory cascade. 12, 13, 15, 17 This state of chronic inflammation is highly associated with disease processes related to obesity, such as type II diabetes and myocardial infarction. 17 Pregnancy, immunity and inflammation Pregnancy is believed to alter the maternal immune system with the number of macrophages, neutrophils and serum CRP concentrations rising significantly. 2, 12, 16, 20 An evolutionary explanation proposes that the maternal immune reaction assists in aborting unhealthy pregnancies whereas allowing healthy ones to continue. 20 As the placenta grows and develops, higher concentrations of immunosuppressant factors such as progesterone and IL-10 are released. 20 From this maternal-placental interaction, there is a balance that is achieved between the enhanced immune response (for example, increased circulating monocytes and neutrophils) and the immunosuppressive effects of pregnancy. 12, 14, 20 Obesity, pregnancy and inflammation Obesity and pregnancy individually contribute to a state of chronic inflammation. It has been suggested that the combined inflammatory response can be particularly harmful for both the mother and the fetus (Figure 1) . 2, 12 Chorioamnionitis is more common in obese pregnant women and has been implicated in the pathogenesis of premature rupture of the membranes, premature birth, increased neonatal mortality rates and a higher rate of cerebral palsy in survivors. 6, 9, 12 This may be due to the increased susceptibility to inflammation and infection secondary to maternal obesity. 13, 21 Obesity is also associated with the development of preeclampsia. A four-unit increase in BMI has been linked to a 40% increased risk of preeclampsia. 4, 6, 22 Preeclampsia is thought to be related to impaired early placentation and presents with hypertension, coagulation abnormalities and decreased uteroplacental blood flow. 2, 18, 23 Preeclampsia can lead to maternal renal and liver failure and is the leading cause of maternal and fetal morbidity globally. 2, 23 Physiologically, preeclampsia and obesity share several common attributes, with both being considered a systemic intravascular inflammatory response. 2, 20 Both are independently associated with dyslipidemia, hyperinsulinemia and glucose intolerance. 2 Preeclampsia is a form of vascular disease that may cause an inadequate oxygen supply to the placenta, resulting in hypoxic tissue that initiates an inflammatory response. 19 In obesity, heightened levels of circulating glucose can create a hypoxic state by glycosylating hemoglobin, leading to decreased oxygen affinity and delivery to peripheral tissues. 19 Oxidative stress may have a key role in initiating neutrophil influx into affected vessels in preeclampsia as well as other obesity-related complications. 2, 16 Furthermore, concentrations of CRP, leptin and macrophage chemotactic protein-1 are elevated in obese pregnant women as well as women who subsequently develop preeclampsia. 12, 14, 17 High CRP levels correlate with endothelial dysfunction and associated hypertension in preeclamptic, as well as obese women. 16 The increased risk of developing preeclampsia in maternal obesity occurs when levels of CRP and other cytokines (for example, TNF-a and IL-6) increase. 23 Vascular changes in obesity and preeclamptic pregnancies are also similar. An imbalance between vasoconstrictors (thromboxane) and vasodilators (prostacyclin) exists, favoring vasocontriction in preeclampsia. 2 In obese individuals, hyperlipidemia reduces Pregnancy complications related to obesity M Schmatz et al prostacyclin secretion and enhances peroxidase production, leading to vasoconstriction and platelet aggregation. 22 Arterioles in the placentas from preeclamptic pregnancies have lesions characteristic of atherosclerotic plaques. 14 The similarities between preeclampsia and obesity are so striking that the vessels of obese women without preeclampsia have been found to closely resemble those of normal weight, preeclamptic women. 2 The heightened oxidative and immune stress of pregnancy exacerbates the inflammatory response of obesity, serving as a foundation for the development of preeclampsia with a smaller threshold of physiologic events necessary to initiate the progression of the disease. 2, 16, 20 Pregnancy complications related to maternal obesity Multiple complications of obesity in pregnancy have been identified and can increase the risk of prenatal, intrapartum and neonatal morbidity ( Table 2 ). Maternal and perinatal risks are related to the degree of obesity and there is evidence of a 'dose effect' of higher BMI on the complications during pregnancy, with class III obesity conferring the highest risk compared to class I, II or normal weight mothers. 4 Figure 1 The interplay between obesity, pregnancy, inflammation and disease. Delivery complications 3, 19 Cesarean section 3, 6, 7 Neonatal complications 11, 21, 25 Breastfeeding failure 26, 27 Postpartum bleeding and infection 4, 8 Abbrevation: PPROM, premature rupture of membranes. a Level of evidence for all references: II.
Pregnancy complications related to obesity M Schmatz et al obesity in pregnancy and its causal relationship to various complications; what is directly attributable to obesity itself compared to the modifiable exposures leading to obesity (high fat or calorie diet or both, lack of exercise and so on) is debeted. Obesity often leads to infertility, frequently secondary to polycystic ovarian syndrome (PCOS), which can contribute to obesity as well as infertility. The PCOS profile involves endocrine dysregulation, amenorrhea, infertility, dyslipidemia and hypertension. 4, 7 Over half of PCOS patients are obese and 25% to 70% experience insulin resistance, which contributes to truncal fat accumulation and abnormal ovulation. 7 Excess abdominal fat even in women without PCOS is associated with glucose intolerance, development of metabolic syndrome, diabetes, cardiovascular disease and infertility. 7, 8, 15 Obese pregnant women have higher rates of both early and late miscarriage. 5, 7 A recent meta-analysis showed that obese women had almost twice the risk of stillbirth than their normal weigh counterparts. 9 It is unclear whether this risk is associated with complications, such as gestational diabetes, hypertension or hyperlipidemia, that may decrease prostacyclin secretion and increase peroxidase production leading to vasoconstriction and platelet aggregation. Other possibilities include a different maternal perception of fetal movement or sleep apnea resulting in apneic and hypoxic episodes. 9 Metabolic derangements more common in obese pregnancies include lipid derangements and gestational diabetes. Elevated leptin levels may explain the association between maternal obesity, hypertriglyceridemia and abnormal levels of high-density lipoprotein characteristic of the metabolic syndrome. 16 Although cholesterol levels normally increase in pregnancy, the increased triglycerides accompanying obesity often result in higher levels in the obese gravidae. The insulin resistance, normally seen in late pregnancy, is exacerbated in obese women; the resulting higher circulating glucose, lipid and amino acid concentrations manifest clinically as gestational diabetes. 18 The risk of gestational diabetes in obese women may be as high as 6 to 14%, 8 and 5 to 10% of these women remain diabetic after delivery. 3, 6, 8 Pregnancy establishes a state of insulin resistance to provide optimal glucose to the fetus, with tissue sensitivity to the hormone decreased by 50 to 60% by the third trimester due to elevated concentrations of insulin antagonists. 8, 19, 28 In addition, intra-abdominal fat, a predisposing risk factor for diabetes, increases during pregnancy. 3, 8, 28 Diabetic pregnant women have an increased risk of birth by cesarean section or operative vaginal delivery increasing the risk of maternal or fetal complications. 28 Intrapartum concerns for obese pregnancies include earlier admission, increased likelihood of induction of labor, difficulties with fetal monitoring and slow progression of labor. 3 This may be secondary to leptin acting to actually inhibiting uterine contractions. 3 Maternal obesity is an independent risk factor for shoulder dystocia and there is a higher risk of planned and emergent cesarean sections. 3, 6, 7 Operative delivery is associated with increased surgical complications such as intraoperative difficulties, bleeding and postpartum infection. 4, 8 The risk of deep venous thrombosis postoperatively, a leading cause of maternal peripartum death, is also increased. 4, 8 Other complications associated with maternal obesity include postpartum hemorrhage, anemia, genital and urinary tract infections, endometriosis, stress incontinence and depression. 4 Obesity has been linked to poor initiation and continuation of breastfeeding. 4, 12, 26 This lactation difficulty may be due to the increased adiposity of the breast tissue, a decreased maternal response to prolactin or mechanical issues facing the obese mother. 26 As such, these mother-infant dyads do not benefit from the multitude of health benefits associated breast feeding, including postpartum weight loss. 21, 27 Obesity and risk to the fetus/newborn Heightened BMI in pregnancy increases the risk to the fetus, newborn and even developing child. Maternal obesity is considered an independent risk factor for fetal mortality with the incidence of late fetal death rising proportionally with increasing BMI in nulliparous women. 9, 22 Infants born to obese mothers have an almost twofold increased risk of death before the first year of life. 29 Preterm delivery is also a serious concern in pregnancies involving obese women. Infants born to mothers with a BMIX35 are at increased risk for all causes of premature birth and neonatal death. 24 In the past decade, the incidence of preterm delivery has risen (now up to 13% according to the March of Dimes), closely paralleling the rising rate of maternal obesity. Although morbid obesity has been shown to have a protective effect against spontaneous preterm deliveries likely by decreasing the amount of myometrial contractions, there is a higher incidence of preterm delivery among obese women for other obstetrical indications including premature rupture of membranes and preeclampsia. 5, 24 For obese mothers with premature rupture of the membranes, there is a sixfold elevated risk of infant mortality. 10 It is speculated that infection causes premature rupture of membranes and chorioamnionitis, which initiates a local immune response and cytokine cascade resulting in premature labor and delivery. 10 If the infectious agent reaches the fetus, it can stimulate a systemic inflammatory reaction involving elevated fetal concentrations of IL-6 and infiltration/activation of neutrophils and monocytes. 30 IL-1, IL-6, IL-8 and TNF-a have been implicated in premature birth as well as neonatal brain damage. 30 In obese women, endothelial cell dysfunction, cytokines and inflammation may assist in rapid progression and heightened severity of obesity-related birth complications. 10 Babies born to morbidly obese women have lower Apgar scores at birth, which have been linked to cerebral palsy, neonatal seizures and death.
11 Obesity-related placental insufficiency, labor and delivery complications, and even the exaggerated cytokine environment may contribute to these lower Apgar scores.
11
Perinatal programming: obesity and the intrauterine environment The long-standing nature versus nurture debate likely applies to the development of obesity, type II diabetes and the metabolic syndrome. It has been speculated that an abnormal intrauterine environment could later contribute to a variety of disease processes occurring during adulthood. Although individuals may be genetically predisposed, the Barker hypothesis of fetal programming suggests that the maternal endocrine and nutritional environment may affect fetal body weight regulation, metabolism and appetite. 4, 7, 12, 18, 31 The intrauterine environment of an obese woman may establish an 'overnourished' fetal state and contribute to the development of certain obesity-related conditions.
In gestational diabetes, maternal insulin resistance with hyperinsulinemia and elevated glucose levels lead to fetal neuroendocrine imprinting. 19,32 -34 In this environment, the fetal pancreas secretes an excessive amount of insulin leading to macrosomia with increased adipose tissue and glycogen deposition. 34 Excess adiposity at birth has been implicated in the later development of childhood obesity; an increase of 1 kg in birth weight of a full-term infant confers a 50% heightened risk of becoming overweight between the ages of 9 and 14. 8, 34 Large for gestational age (LGA) infants of diabetic mothers are also at heightened risk of developing metabolic syndrome, diabetes and cardiovascular insults later in life. 35 Children exposed to the intrauterine environment of an obese mother have an increased risk of developing metabolic syndrome, similar to children of diabetic mothers. 35 Fetal leptin regulatory programming may be the link between the exposure to maternal diabetes and obesity in childhood. 34 Leptin levels are positively correlated with hyperinsulemia, birth weight and adiposity, with LGA infants having higher cord leptin concentrations than normal controls. 18, 33, 34 As leptin and insulin are intimately involved in normal metabolic homeostasis, the elevated birth levels of infants born to obese and diabetic women may indicate an acquired hypothalamic resistance that is associated with the later development of childhood obesity. 33 Controversy continues regarding whether obesity is a significant risk factor for congenital structural abnormalities such as neural tube defects. Folic acid metabolism abnormalities and insulin resistance have been considered potential teratogens. 36 Neural tube defects and other congenital anomalies have been linked to poor glycemic control and are more common in obese mothers, even in nondiabetic women. 6 In addition, the placentas of obese women have been found to be larger than normal controls; placental size positively correlates with fetal size. 19 As the placenta releases leptin into the maternal circulation, an enlarged placenta may accentuate the fetus' exposure to this adipokine. 18 Recent studies have also established a relationship between an enlarged placenta and the later development of hypertension, coronary heart disease and diabetes in children. 19 
Conclusion
Reaching epidemic proportions worldwide, obesity has significant health implications across the life span. Obesity can predispose pregnant women to gestational diabetes, preeclampsia, and labor and delivery complications. Systemic inflammation created by superimposed obesity and pregnancy imparts additional risks of infection, premature delivery and severe preeclampsia. The inflammatory intrauterine environment may cause premature birth, macrosomia, congenital structural defects, neurologic injury and low Apgar scores in the infant. Obesity is considered one of the most common, preventable risk factors independently associated with neonatal and childhood morbidity. Maternal obesity establishes a suboptimal intrauterine environment, which ultimately contributes to the development of childhood obesity, type II diabetes and metabolic syndrome. It is potentially this fetal programming, that perpetuates the vicious cycle of family-linked obesity-related complications. Obesity in women of reproductive age can have far reaching implications for fertility, pregnancy, the fetus and neonate as well as life-long health of the mother and her child. Intensive population-based intervention trials are needed to determine if reductions in weight or changes in diet or lifestyle will ultimately improve outcome for pregnant mothers and their infants.
